Ozempic Maker's Parent Company To Invest $7B Annually By 2030: 'We Have More Money Than Ever To Invest'
Novo Holdings, the major shareholder of Danish pharmaceutical company Novo Nordisk, plans to ramp up its annual investments to $7 billion by 2030.
